{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:03:35Z","timestamp":1784257415867,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012536","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000}}],"reference-count":72,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012536.pub2","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:56:11Z","timestamp":1501894571000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antiepileptic drugs for chronic non-cancer pain in children and adolescents"],"prefix":"10.1002","author":[{"given":"Tess E","family":"Cooper","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C","family":"Heathcote","sequence":"additional","affiliation":[{"name":"Stanford University; Department of Anesthesiology, Perioperative and Pain Medicine; 1070 Arastradero Road, Suite 300 Palo Alto California USA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Clinch","sequence":"additional","affiliation":[{"name":"Bristol Royal Hospital for Children; Paediatric Rheumatology; Bristol UK"},{"name":"Bath Centre for Pain Services; Child\/Adolescent Pain; Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Howard","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital; Anaesthesia and Pain Management; Great Ormond Street London UK WC1N 3JH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Krane","sequence":"additional","affiliation":[{"name":"Stanford University; Anaesthesiology, Perioperative & Pain Medicine, and Paediatrics; 300 Pasteur Drive Stanford CA USA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Lord","sequence":"additional","affiliation":[{"name":"John Hunter Children\u2019s Hospital; Children\u2019s Complex Pain Service; Newcastle New South Wales (NSW) Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navil","family":"Sethna","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital; Anesthesiology, Perioperative and Pain Medicine; Boston Massachusetts USA"},{"name":"Boston Children\u2019s Hospital; Mayo Family Pediatric Pain Rehabilitation Center; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Schechter","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital; Anesthesiology, Perioperative and Pain Medicine; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Wood","sequence":"additional","affiliation":[{"name":"University Hospital Dupuytren; Rheumatology; Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-016-0106-4","article-title":"Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study","volume":"14","author":"Arnold","year":"2016","journal-title":"Pediatric Rheumatology"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.sjpain.2016.05.039","article-title":"A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children","volume":"13","author":"Brown","year":"2016","journal-title":"Scandinavian Journal of Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD012536.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2014.05.002","article-title":"An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache","volume":"342","author":"Kalita","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"issue":"8","key":"10.1002\/14651858.CD012536.pub2-BIB0004|cit4","first-page":"961","article-title":"Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study","volume":"59","author":"Ogawa","year":"2010","journal-title":"Masui. The Japanese Journal of Anesthesiology"},{"issue":"3","key":"10.1002\/14651858.CD012536.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4103\/0970-9290.87062","article-title":"Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: a double blind randomized clinical trial","volume":"22","author":"Pramod","year":"2011","journal-title":"Indian Journal of Dental Research"},{"issue":"4","key":"10.1002\/14651858.CD012536.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025127723729","article-title":"Use of gabapentin to reduce chronic neuropathic pain in Fabry disease","volume":"26","author":"Ries","year":"2003","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"6","key":"10.1002\/14651858.CD012536.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.sc.3101300","article-title":"Gabapentin for neuropathic pain following spinal cord injury","volume":"40","author":"To","year":"2002","journal-title":"Spinal Cord"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0008|cit8","first-page":"1","article-title":"Gabapentin vs. pregabalin for the treatment of neuropathic pain in patients with spinal cord injury: A crossover study","volume":"61","author":"Yilmaz","year":"2015","journal-title":"Turkish Journal of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0009|cit9","unstructured":"American Medical Association Pediatric pain management https:\/\/www.ama-assn.org\/"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0010|cit10","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/14737175.9.1.3","article-title":"Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures","volume":"9","author":"Beydoun","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(62)91847-0","article-title":"Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G.32883)","volume":"1","author":"Blom","year":"1962","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/j.pain.0000000000000403","article-title":"A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010","volume":"157","author":"Caes","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0014|cit14","first-page":"129","article-title":"Anticonvulsants for the management of pain","volume":"7","author":"Chong","year":"2000","journal-title":"Pain Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002508-200301000-00008","article-title":"The rationale and use of topiramate for treating neuropathic pain","volume":"19","author":"Chong","year":"2003","journal-title":"Clinical Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD012536.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012538.pub2","article-title":"Opioids for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012536.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012535.pub2","article-title":"Antidepressants for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012536.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012563.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012536.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012539.pub2","article-title":"Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-540-33823-9_6","article-title":"Anti-convulsants and anti-depressants","volume":"177","author":"Dickenson","year":"2007","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/bmj.326.7404.1408","article-title":"Management of chronic pain in children and adolescents (Editorial)","volume":"326","author":"Eccleston","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD012536.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012537.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents","author":"Eccleston","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Molecular Pharmacology"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0028|cit28","unstructured":"Federal Drug Administration Epilepsy Drugs Get Suicide Risk Warning http:\/\/www.webmd.com\/epilepsy\/news\/20081216\/epilepsy-drugs-get-suicide-risk-warning"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE Guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0033|cit33","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00002508-200012000-00008","article-title":"Lamotrigine in the management of neuropathic pain","volume":"16","author":"McCleane","year":"2000","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0037|cit37","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD012536.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0039|cit39","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012536.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012536.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012536.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.2013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012536.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012536.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012536.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012536.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpain.2008.04.007","article-title":"Core outcome domains and measures for pediatric acute and chronic\/recurrent pain clinical trials: PedIMMPACT","volume":"9","author":"McGrath","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0056|cit56","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2008.12.005","article-title":"Pain therapy","volume":"70","author":"Ripamonti","year":"2008","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012536.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bjaceaccp\/mki003","article-title":"Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs","volume":"5","author":"Ryder","year":"2005","journal-title":"Continuing Education in Anaesthesia"},{"issue":"1-2","key":"10.1002\/14651858.CD012536.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2006.05.006","article-title":"Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents","volume":"125","author":"Stinson","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012536.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mehy.2004.07.019","article-title":"The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate","volume":"64","author":"Toth","year":"2005","journal-title":"Medical Hypotheses"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0065|cit65","unstructured":"United Nations World population prospects 2015 - population indicators esa.un.org\/unpd\/wpp\/Download\/Standard\/Population\/"},{"issue":"1-2","key":"10.1002\/14651858.CD012536.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pain.2006.08.014","article-title":"Systematic review of observational (behavioural) measures of pain for children and adolescents aged 3 to 18 years","volume":"127","author":"Baeyer","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0067|cit67","volume-title":"WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses","author":"World Health Organization","year":"2012"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0068|cit68","unstructured":"World Health Organization 19th WHO model list of essential medicines www.who.int\/medicines\/publications\/essentialmedicines\/EML2015_8-May-15.pdf"},{"issue":"11","key":"10.1002\/14651858.CD012536.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012536.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012564.pub2","article-title":"Opioids for cancer-related pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012536.pub2-BIB0071|cit71","unstructured":"World Bank Data - population ages 0-14 (% of total) data.worldbank.org\/indicator\/SP.POP.0014.TO.ZS"},{"issue":"2","key":"10.1002\/14651858.CD012536.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.110.171108","article-title":"The anticonvulsant drug lamotrigine blocks neuronal{alpha}4{beta}2-nicotinic acetylcholine receptors","volume":"335","author":"Zheng","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012536.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:08:00Z","timestamp":1628550480000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012536.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012536.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}